Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Is there any role in continuing apixaban in a patient with occlusion of the right internal jugular vein with chronic postthrombotic change to prevent a recurrent DVT?
Previous provoking factors resolved (CVC, malignancy, etc)
Answer from: at Academic Institution
Yes
Sign in or Register to read more
15620
Related Questions
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
Can you use apixaban or rivaroxaban in case of dabigatran failure?
How would you manage a chronic thrombosis of the internal jugular vein?
Are SCDs contraindicated in patients with acute DVTs?
How do you approach the management of PFO in a young person with a cryptogenic CVA?
Would you recommend indefinite anticoagulation in any scenario of a provoked clot?
In extremely obese patients with spontaneous DVT/PE who have been anticoagulated for > 6 months, do you feel comfortable reducing the DOAC to prophylactic dose or do you prefer continuing full dose indefinite anticoagulation?
For a patient with ESRD on hemodialysis with recurrent AV fistula thrombosis and a finding of Protein C deficiency based on decreased plasma activity level on thrombophilia workup, what is recommended in terms of anticoagulation management?
How long post operatively do you wait before transitioning from parenteral anticoagulation to oral anticoagulants after pulmonary thromboendarterectomy for CTEPH?
How do you manage me anticoagulation in a patient with May Thurner Syndrome, who does not have history of thrombosis, and becomes pregnant?